• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Yes 相关蛋白 1 通过调节肿瘤相关巨噬细胞中 GLUT3 依赖性糖代谢重编程促进胃癌对 5-氟尿嘧啶的耐药性。

Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages.

机构信息

Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.

Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China; Department of General Surgery, Zhuhai People's Hospital, Guangzhou, Guangdong, China.

出版信息

Arch Biochem Biophys. 2021 May 15;702:108838. doi: 10.1016/j.abb.2021.108838. Epub 2021 Mar 13.

DOI:10.1016/j.abb.2021.108838
PMID:33727040
Abstract

The antimetabolite 5-fluorouracil (5-FU) is a widely used chemotherapy regimen for the treatment of gastric cancer (GC). However, resistance to 5-FU remains a major drawback in the clinical use. The treatments of anti-tumor chemo-agents recruit tumor associated macrophages (TAMs) which are highly implicated in the chemoresistance development, but the underlying molecular mechanism is unclear. Here, we demonstrate that YAP1 is overexpressed in resistant GC tissues compared to sensitive GC tissues. Further, IL-3 secreted by YAP1-overexpressed GC could skew macrophage polarization to M2-like phenotype and inducing GLUT3-depended glycolysis program. Meanwhile, polarized M2 macrophages enhance 5-FU resistance in tumor cells by secreting CCL8 and activating phosphorylation of JAK1/STAT3 signaling pathway.

摘要

代谢拮抗剂 5-氟尿嘧啶(5-FU)是一种广泛用于治疗胃癌(GC)的化疗方案。然而,对 5-FU 的耐药性仍然是临床应用的主要障碍。抗肿瘤化疗药物的治疗会招募肿瘤相关巨噬细胞(TAMs),这些细胞在耐药性的发展中高度涉及,但潜在的分子机制尚不清楚。在这里,我们证明 YAP1 在耐药性 GC 组织中的表达高于敏感性 GC 组织。此外,YAP1 过表达的 GC 分泌的白细胞介素 3(IL-3)可以将巨噬细胞极化为 M2 样表型,并诱导 GLUT3 依赖的糖酵解程序。同时,极化的 M2 巨噬细胞通过分泌 CCL8 和激活 JAK1/STAT3 信号通路的磷酸化来增强肿瘤细胞对 5-FU 的耐药性。

相似文献

1
Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages.Yes 相关蛋白 1 通过调节肿瘤相关巨噬细胞中 GLUT3 依赖性糖代谢重编程促进胃癌对 5-氟尿嘧啶的耐药性。
Arch Biochem Biophys. 2021 May 15;702:108838. doi: 10.1016/j.abb.2021.108838. Epub 2021 Mar 13.
2
Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.肿瘤衍生的 LIF 通过激活胃癌中的肿瘤相关巨噬细胞促进化疗耐药性。
Exp Cell Res. 2021 Sep 1;406(1):112734. doi: 10.1016/j.yexcr.2021.112734. Epub 2021 Jul 13.
3
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.肿瘤细胞中激活的 HIF1α 通过招募产生 GDF15 的肿瘤相关巨噬细胞促进胃癌的化疗耐药发展。
Cancer Immunol Immunother. 2020 Oct;69(10):1973-1987. doi: 10.1007/s00262-020-02598-5. Epub 2020 May 9.
4
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.Nogo-B 通过增强 Yap/Taz 介导的肿瘤相关巨噬细胞 M2 极化促进 HCC 进展。
Exp Cell Res. 2020 Jun 1;391(1):111979. doi: 10.1016/j.yexcr.2020.111979. Epub 2020 Apr 1.
5
Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.转移性结直肠癌通过 Glut3-YAP 依赖的信号通路重写代谢程序。
Theranostics. 2019 Apr 13;9(9):2526-2540. doi: 10.7150/thno.32915. eCollection 2019.
6
Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.黄芩素通过抑制糖酵解和PTEN/Akt/HIF-1α信号通路逆转缺氧诱导的胃癌AGS细胞对5-氟尿嘧啶的耐药性。
Oncol Rep. 2015 Jan;33(1):457-63. doi: 10.3892/or.2014.3550. Epub 2014 Oct 17.
7
Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway.再生家族成员4(Reg4)通过激活MAPK/Erk/Bim信号通路增强胃癌对5-氟尿嘧啶的耐药性。
Med Sci Monit. 2017 Jul 31;23:3715-3721. doi: 10.12659/msm.903134.
8
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.YAP1在体外和体内均可增强胃癌细胞的增殖、迁移和侵袭能力。
Oncotarget. 2016 Dec 6;7(49):81062-81076. doi: 10.18632/oncotarget.13188.
9
Hyaluronan-mediated motility receptor confers resistance to chemotherapy TGFβ/Smad2-induced epithelial-mesenchymal transition in gastric cancer.透明质酸介导的运动受体赋予胃癌对化疗 TGFβ/Smad2 诱导的上皮间质转化的抗性。
FASEB J. 2019 May;33(5):6365-6377. doi: 10.1096/fj.201802186R. Epub 2019 Feb 25.
10
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.卵叶二萜内酯通过YAP致癌途径抑制结肠肿瘤发生并阻止M2肿瘤相关巨噬细胞极化。
J Hematol Oncol. 2017 Feb 28;10(1):60. doi: 10.1186/s13045-017-0421-3.

引用本文的文献

1
Research progress on mechanisms of tumor immune microenvironment and gastrointestinal resistance to immunotherapy: mini review.肿瘤免疫微环境与胃肠道免疫治疗抵抗机制的研究进展:综述
Front Immunol. 2025 Jul 25;16:1641518. doi: 10.3389/fimmu.2025.1641518. eCollection 2025.
2
Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications.靶向肿瘤相关巨噬细胞在胃癌进展和治疗中的作用:从分子机制到治疗应用的见解
Front Pharmacol. 2025 Jun 17;16:1549694. doi: 10.3389/fphar.2025.1549694. eCollection 2025.
3
Immunometabolism of Innate Immune Cells in Gastrointestinal Cancer.
胃肠道癌中固有免疫细胞的免疫代谢
Cancers (Basel). 2025 Apr 27;17(9):1467. doi: 10.3390/cancers17091467.
4
Single-Cell Profiling Reveals Global Immune Responses During the Progression of Murine Epidermal Neoplasms.单细胞分析揭示小鼠表皮肿瘤进展过程中的整体免疫反应。
Cancers (Basel). 2025 Apr 21;17(8):1379. doi: 10.3390/cancers17081379.
5
Warburg effect and lactylation in cancer: mechanisms for chemoresistance.癌症中的瓦伯格效应与乳酸化:化疗耐药机制
Mol Med. 2025 Apr 22;31(1):146. doi: 10.1186/s10020-025-01205-6.
6
Selinexor's Immunomodulatory Impact in Advancing Multiple Myeloma Treatment.塞利尼索在推进多发性骨髓瘤治疗中的免疫调节作用。
Cells. 2025 Mar 13;14(6):430. doi: 10.3390/cells14060430.
7
Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer.肿瘤微环境对胃癌免疫耐受的临床意义
Front Immunol. 2025 Feb 14;16:1532605. doi: 10.3389/fimmu.2025.1532605. eCollection 2025.
8
A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes.一种基于凝血和巨噬细胞相关基因相互作用指导个性化免疫治疗的肺腺癌新型分类方法。
Front Immunol. 2025 Feb 13;16:1518102. doi: 10.3389/fimmu.2025.1518102. eCollection 2025.
9
The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy.巨噬细胞在各类肿瘤中的作用及其作为抗肿瘤治疗靶点的可能性。
Cancers (Basel). 2025 Jan 21;17(3):342. doi: 10.3390/cancers17030342.
10
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease.河马-YAP1/TAZ信号通路在代谢功能障碍相关脂肪性肝病中的调控
Front Pharmacol. 2025 Jan 23;16:1505117. doi: 10.3389/fphar.2025.1505117. eCollection 2025.